Kadmon Holdings, Inc. (KDMN)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0.0% (0 of 2*)
Rating Return
-5.14% vs
Rating Accuracy
0.0% (0 of 3*)
FV Performance
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0.0% Hit Rate)
FV Avg. Distance
+41.84%
FV Accuracy
3 Hits (6.12% Hit Rate)
FV Avg. Distance
+59.16%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Harlan W. Waksal
Employees
115
Industry
Transplantation Biopharmaceuticals
Sector
Healthcare
Headquarters
New York
Exchange
New York Stock Exchange
Website
http://www.kadmon.comSummary Stats
Market Cap
1.7B
Revenue
16.1M
Net Income
-122M
EPS
-$0.71
Price-to-Earnings
-13.43
Price-to-Book
126.26
Debt-to-Equity
21.65
News
Analyst Ratings
Price targets projected by 6 analysts
High
$25.00
Average
$12.67
Low
$8.00
Ratings calculated by 0 analysts
Buy
0
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q3 2021
Missed by $0.00
-$0.20 +-0.0%
-0.2
-0.15
Down 33%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--